Company: KNRX
Filing Date: 2025-09-30
Form Type: 424B4
Source: 0001493152-25-016175
Chunk: 69

Company: KNOREX LTD.
Filing Date: 2025-09-30
Form: 424B4
Chunk 69
---
 2,390 |   |     |           |       2,390 |   |     |              |       2,390 |   |
| Additional paid-in capital                                                                                                          |     |                |  45,914,112 |   |     |           |  46,116,487 |   |     |              |  55,641,089 |   |
| Accumulated deficit                                                                                                                 |     |                | (49,416,584 | ) |     |           | (49,416,584 | ) |     |              | (49,416,584 | ) |
| Accumulated other comprehensive loss                                                                                                |     |                |    (863,282 | ) |     |           |    (863,282 | ) |     |              |    (863,282 | ) |
| Total shareholders’ (deficit) equity                                                                                                |     |                |  (4,352,124 | ) |     |           |  (4,149,667 | ) |     |              |   5,376,435 |   |
| Non-controlling interests                                                                                                           |     |                |         124 |   |     |           |         124 |   |     |              |         124 |   |
| Total capitalization                                                                                                                |     | $              |     700,497 |   |     | $         |   4,838,518 |   |     | $            |  14,364,620 |   |

You should read the tables together with our consolidated financial statements and the related notes included elsewhere in this prospectus and the information under “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

The discussion and table above exclude the warrants our Company issued on September 30, 2024 to shareholders of the Company, who were previously shareholders of Knorex SG, and certain other persons in exchange for warrants previously issued to them by Knorex SG pursuant to the Restructuring Agreement. See “Description of Share Capital—Warrants” for details.

| 37 |

<div align='center'>DILUTION</div>

If you invest in our Class A Ordinary Shares in this offering, your interest will be diluted immediately to the extent of the difference between the initial public offering price per share and our net tangible book value per share of our ordinary shares (Class A and Class B) after this offering. Dilution results from the fact that the assumed initial public offering price per share is substantially